Wagner Heidi L
SEC CIK 1655029 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| WVE | Wave Life Sciences, Inc. | Dir | 51.9K | — | $231.1K | 6 | 2024-08-12 | 2026-08-11 |
Most active insiders at WVE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | $54.63M | — |
| 2 | GSK plc | 10% | $27.93M | — |
| 3 | Francis Chris | See Remarks | — | $7.10M |
| 4 | Moran Kyle | CFO | — | $4.15M |
| 5 | Tan Aik Na | Dir | — | $1.83M |
| 6 | HENRY CHRISTIAN O | Dir | — | $1.37M |
| 7 | Rawcliffe Adrian | Dir | — | $806.6K |
| 8 | Verdine Gregory L. | Dir | — | $269.5K |
| 9 | Wagner Heidi L | Dir | — | $231.1K |
| 10 | CORRIGAN MARK | Dir | — | $217.3K |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-13 21:00 | 2026-08-11 | WVE | Wave Life Sciences, Inc. | Wagner Heidi L | Dir | M - OptEx | $5.97 | +7,000 | 51.9K | +16% | +$41.8K |
| DT | 2026-08-13 21:00 | 2026-08-11 | WVE | Wave Life Sciences, Inc. | Wagner Heidi L | Dir | S - Sale+OE | $6.01 | -7,000 | 44.9K | -13% | -$42.1K |
| DMT | 2025-12-10 | 2025-12-08 | WVE | Wave Life Sciences, Inc. | Wagner Heidi L | Dir | M - OptEx | $5.97 | +14.0K | 51.9K | +37% | +$83.6K |
| DMT | 2025-12-10 | 2025-12-08 | WVE | Wave Life Sciences, Inc. | Wagner Heidi L | Dir | S - Sale+OE | $13.50 | -14.0K | 44.9K | -24% | -$189.0K |
| D | 2025-08-13 | 2025-08-11 | WVE | Wave Life Sciences, Inc. | Wagner Heidi L | Dir | A - Grant | $0.00 | +12.7K | 44.9K | +39% | $0 |
| D | 2024-08-14 | 2024-08-12 | WVE | Wave Life Sciences, Inc. | Wagner Heidi L | Dir | A - Grant | $0.00 | +32.2K | 32.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations